161000 — AekyungChemical Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩605bn
- KR₩845bn
- KR₩2tn
- 44
- 69
- 41
- 50
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 137,244 | 135,958 | 70,985 | 107,572 | 99,304 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 64,760 | 64,094 | 210,132 | 190,464 | 236,297 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 298,123 | 296,203 | 604,837 | 591,670 | 587,429 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 135,290 | 177,902 | 532,363 | 576,619 | 620,761 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 492,826 | 532,150 | 1,244,966 | 1,234,084 | 1,308,361 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 121,170 | 126,114 | 481,911 | 473,850 | 480,051 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 129,616 | 137,633 | 552,060 | 505,967 | 571,962 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 363,211 | 394,517 | 692,906 | 728,117 | 736,399 |
Total Liabilities & Shareholders' Equity | 492,826 | 532,150 | 1,244,966 | 1,234,084 | 1,308,361 |
Total Common Shares Outstanding |